Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2017

May 30, 2017

284_dirs_2017-05-30_3e6f82a8-a81e-4aaa-bced-1896940ec439.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2017-05-26

Reporting Person: LAZARUS ROCHELLE B (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-05-26 Phantom Stock $ A 2618.6075 Acquired Common Stock (2618.6075) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4594.0000 Direct
Common Stock 1757.0000 Indirect

Footnotes

F1: 1-for-1

F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

F3: Holdings include shares acquired in dividend reinvestment transactions.